Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
434 questions in 75 reviews · Metabolic and Endocrine Disorders
current versionsNo studies 434 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Diabetic complications · patients with type 1 diabetes mellitus Continuous glucose monitoring systems for type 1 diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Death from any cause · adults with diabetes mellitus and depression Psychological and pharmacological interventions for depression in patients with diabetes mellitus and… (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Healthcare costs · adults with diabetes mellitus and depression Psychological and pharmacological interventions for depression in patients with diabetes mellitus and… (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Diabetes complications · adults with diabetes mellitus and depression Psychological and pharmacological interventions for depression in patients with diabetes mellitus and… (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Death from any cause · adults with diabetes mellitus and depression Psychological and pharmacological interventions for depression in patients with diabetes mellitus and… (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Diabetes complications · adults with diabetes mellitus and depression Psychological and pharmacological interventions for depression in patients with diabetes mellitus and… (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR All‐cause mortality · overweight or obese adults Green tea for weight loss and weight maintenance in overweight or obese adults (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Morbidity · overweight or obese adults Green tea for weight loss and weight maintenance in overweight or obese adults (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · overweight or obese adults Green tea for weight loss and weight maintenance in overweight or obese adults (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Patient satisfaction · overweight or obese adults Green tea for weight loss and weight maintenance in overweight or obese adults (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Costs · overweight or obese adults Green tea for weight loss and weight maintenance in overweight or obese adults (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Morbidity · patients with type 2 diabetes mellitus Colesevelam for type 2 diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Mortality · patients with type 2 diabetes mellitus Colesevelam for type 2 diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · patients with type 2 diabetes mellitus Colesevelam for type 2 diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Functional outcomes · patients with type 2 diabetes mellitus Colesevelam for type 2 diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Costs · patients with type 2 diabetes mellitus Colesevelam for type 2 diabetes mellitus (2012) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Development of diabetic complications · patients with LADA Interventions for latent autoimmune diabetes (LADA) in adults (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · patients with LADA Interventions for latent autoimmune diabetes (LADA) in adults (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Death from any cause · patients with LADA Interventions for latent autoimmune diabetes (LADA) in adults (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health service utilisation and costs · patients with LADA Interventions for latent autoimmune diabetes (LADA) in adults (2011) · Cochrane | no estimate extracted | NR | No studies |
Insulin detemir (intervention) vs Insulin glargin (control) Mortality ‐ not reported · patients with type 2 diabetes mellitus Insulin detemir versus insulin glargine for type 2 diabetes mellitus (2011) · Cochrane | no estimate extracted | NR | No studies |
Insulin detemir (intervention) vs Insulin glargin (control) Quality of life and treatment satisfaction ‐ not reported · patients with type 2 diabetes mellitus Insulin detemir versus insulin glargine for type 2 diabetes mellitus (2011) · Cochrane | no estimate extracted | NR | No studies |
Xuezhikang vs simvastatin Cardiovascular events ‐ not reported · patients with hypercholesterolemia Chinese herbal medicines for hypercholesterolemia (2011) · Cochrane | no estimate extracted | NR | No studies |
Xuezhikang vs pravastatin Health‐related quality of life ‐ not reported · patients with hypercholesterolemia Chinese herbal medicines for hypercholesterolemia (2011) · Cochrane | no estimate extracted | NR | No studies |
Xuezhikang vs pravastatin Health costs · patients with hypercholesterolemia Chinese herbal medicines for hypercholesterolemia (2011) · Cochrane | no estimate extracted | NR | No studies |
Xuezhikang vs simvastatin Death from any cause ‐ not reported · patients with hypercholesterolemia Chinese herbal medicines for hypercholesterolemia (2011) · Cochrane | no estimate extracted | NR | No studies |
Xuezhikang vs simvastatin Health‐related quality of life ‐ not reported · patients with hypercholesterolemia Chinese herbal medicines for hypercholesterolemia (2011) · Cochrane | no estimate extracted | NR | No studies |
Xuezhikang vs simvastatin Health costs ‐ not reported · patients with hypercholesterolemia Chinese herbal medicines for hypercholesterolemia (2011) · Cochrane | no estimate extracted | NR | No studies |
Xuezhikang vs pravastatin Cardiovascular events ‐ not reported · patients with hypercholesterolemia Chinese herbal medicines for hypercholesterolemia (2011) · Cochrane | no estimate extracted | NR | No studies |
Xuezhikang vs pravastatin Death from any cause ‐ not reported · patients with hypercholesterolemia Chinese herbal medicines for hypercholesterolemia (2011) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Morbidity · type 2 diabetes mellitus Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus (2008) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · type 2 diabetes mellitus Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus (2008) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Morbidity · patients with type 2 diabetes mellitus Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus (2008) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · patients with type 2 diabetes mellitus Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus (2008) · Cochrane | no estimate extracted | NR | No studies |